Synektik (WAR:SNT) Notes Receivable: zł0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SNT Synektik SA WAR:SNT
89 GF Score
Price zł355.60
GF Value zł292.46
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Synektik Notes Receivable?

Synektik WAR:SNT -0.39% 89 Notes Receivable is zł0.0 Mil as of Jun. 2026. GuruFocus rates WAR:SNT with a GF Score™ of 89/100 and a GF Value™ of zł292.46 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Synektik's Notes Receivable for the quarter that ended in Jun. 2026 was zł0.0 Mil.

Synektik Notes Receivable Historical Data

* Premium members only.

The historical data trend for Synektik's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Notes Receivable Chart

Synektik Annual Data
Trend Dec14 Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Synektik Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:SNT
89GF Score
Synektik SA WAR:SNT
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synektik Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of zł0.0 Mil mean?
Synektik (WAR:SNT) has a Notes Receivable of zł0.0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Synektik and its competitors.
Is Synektik's Notes Receivable too high?
Synektik's current Notes Receivable is zł0.0 Mil. Overall, Synektik has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Notes Receivable compare to ABT and SYK?
Synektik's Notes Receivable of zł0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Synektik and its competitors. Synektik's current Notes Receivable is zł0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (WAR:SNT) is currently considered Modestly Overvalued. The stock's GF Value™ is zł292.46, compared to a current price of zł355.60 — trading 21.6% above its estimated fair value. The current Notes Receivable is zł0.0 Mil. Synektik's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Synektik (WAR:SNT), the current Notes Receivable is zł0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (WAR:SNT) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of zł355.60 is trading 21.6% above its estimated GF Value™ of zł292.46. GuruFocus considers Synektik to be Modestly Overvalued.

Key valuation signals for WAR:SNT:

  • Notes Receivable: zł0.0 Mil
  • GF Value™: zł292.46 vs. price of zł355.60 (21.6% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the WAR:SNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synektik Business Description

Other Exchanges A2P:Germany
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
89GF Score

Get the complete analysis for WAR:SNT

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł355.60
Price
zł292.46
GF Value